The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma

Ryota Souzaki, Tatsuro Tajiri, Risa Teshiba, Mayumi Higashi, Yoshiaki Kinoshita, Sakura Tanaka, Tomoaki Taguchi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: MYCN amplification (MYCN-A) is a strong prognostic factor in neuroblastoma (NB). MYCN gain which is a low level of MYCN-A as determined by FISH. It is unclear whether the MYCN gain is the pre-status of MYCN-A. This study assessed the status of MYCN gene and chromosome 2p of MYCN-A, MYCN gain and no MYCN amplification using a single nucleotide polymorphism (SNP) array, and the clinical implication of MYCN gain in NB. Methods: The status of the MYCN gene was determined by FISH in 47 primary NB samples and the status of chromosome 2p in all cases was analyzed using an SNP array. Results: 8 of the 47 cases analyzed using FISH showed MYCN-A, 7 cases showed MYCN gain and 32 cases showed no MYCN amplification. An SNP array analysis showed that only 2 of 8 cases with MYCN-A by FISH had both amplification of MYCN region and distal 2p gain and other 6 cases had amplification of the MYCN region without distal 2p gain. All 7 cases with MYCN gain by FISH had distal 2p gain without amplification of the MYCN region, and all 32 cases with no MYCN amplification by FISH demonstrated neither the amplification of the MYCN region nor the 2p gain. 5-year overall survival rate of patients with MYCN gain (n = 7, 71.4%) was not significant different from that of patients with no MYCN amplification (n = 32, 90.6%) by FISH (p = 0.11). Conclusions: These results suggested that the MYCN gain detected by FISH represents the 2p gain, and the MYCN gain is not considered to represent the pre-status of MYCN amplification.

Original languageEnglish
Pages (from-to)231-236
Number of pages6
JournalPediatric surgery international
Volume27
Issue number3
DOIs
Publication statusPublished - Mar 1 2011

Fingerprint

Neuroblastoma
Single Nucleotide Polymorphism
Chromosomes
Genes
Survival Rate

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma. / Souzaki, Ryota; Tajiri, Tatsuro; Teshiba, Risa; Higashi, Mayumi; Kinoshita, Yoshiaki; Tanaka, Sakura; Taguchi, Tomoaki.

In: Pediatric surgery international, Vol. 27, No. 3, 01.03.2011, p. 231-236.

Research output: Contribution to journalArticle

Souzaki, Ryota ; Tajiri, Tatsuro ; Teshiba, Risa ; Higashi, Mayumi ; Kinoshita, Yoshiaki ; Tanaka, Sakura ; Taguchi, Tomoaki. / The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma. In: Pediatric surgery international. 2011 ; Vol. 27, No. 3. pp. 231-236.
@article{14b1c42ab7c64f95815c7a4989f0bf98,
title = "The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma",
abstract = "Purpose: MYCN amplification (MYCN-A) is a strong prognostic factor in neuroblastoma (NB). MYCN gain which is a low level of MYCN-A as determined by FISH. It is unclear whether the MYCN gain is the pre-status of MYCN-A. This study assessed the status of MYCN gene and chromosome 2p of MYCN-A, MYCN gain and no MYCN amplification using a single nucleotide polymorphism (SNP) array, and the clinical implication of MYCN gain in NB. Methods: The status of the MYCN gene was determined by FISH in 47 primary NB samples and the status of chromosome 2p in all cases was analyzed using an SNP array. Results: 8 of the 47 cases analyzed using FISH showed MYCN-A, 7 cases showed MYCN gain and 32 cases showed no MYCN amplification. An SNP array analysis showed that only 2 of 8 cases with MYCN-A by FISH had both amplification of MYCN region and distal 2p gain and other 6 cases had amplification of the MYCN region without distal 2p gain. All 7 cases with MYCN gain by FISH had distal 2p gain without amplification of the MYCN region, and all 32 cases with no MYCN amplification by FISH demonstrated neither the amplification of the MYCN region nor the 2p gain. 5-year overall survival rate of patients with MYCN gain (n = 7, 71.4{\%}) was not significant different from that of patients with no MYCN amplification (n = 32, 90.6{\%}) by FISH (p = 0.11). Conclusions: These results suggested that the MYCN gain detected by FISH represents the 2p gain, and the MYCN gain is not considered to represent the pre-status of MYCN amplification.",
author = "Ryota Souzaki and Tatsuro Tajiri and Risa Teshiba and Mayumi Higashi and Yoshiaki Kinoshita and Sakura Tanaka and Tomoaki Taguchi",
year = "2011",
month = "3",
day = "1",
doi = "10.1007/s00383-010-2781-4",
language = "English",
volume = "27",
pages = "231--236",
journal = "Pediatric Surgery International",
issn = "0179-0358",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma

AU - Souzaki, Ryota

AU - Tajiri, Tatsuro

AU - Teshiba, Risa

AU - Higashi, Mayumi

AU - Kinoshita, Yoshiaki

AU - Tanaka, Sakura

AU - Taguchi, Tomoaki

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Purpose: MYCN amplification (MYCN-A) is a strong prognostic factor in neuroblastoma (NB). MYCN gain which is a low level of MYCN-A as determined by FISH. It is unclear whether the MYCN gain is the pre-status of MYCN-A. This study assessed the status of MYCN gene and chromosome 2p of MYCN-A, MYCN gain and no MYCN amplification using a single nucleotide polymorphism (SNP) array, and the clinical implication of MYCN gain in NB. Methods: The status of the MYCN gene was determined by FISH in 47 primary NB samples and the status of chromosome 2p in all cases was analyzed using an SNP array. Results: 8 of the 47 cases analyzed using FISH showed MYCN-A, 7 cases showed MYCN gain and 32 cases showed no MYCN amplification. An SNP array analysis showed that only 2 of 8 cases with MYCN-A by FISH had both amplification of MYCN region and distal 2p gain and other 6 cases had amplification of the MYCN region without distal 2p gain. All 7 cases with MYCN gain by FISH had distal 2p gain without amplification of the MYCN region, and all 32 cases with no MYCN amplification by FISH demonstrated neither the amplification of the MYCN region nor the 2p gain. 5-year overall survival rate of patients with MYCN gain (n = 7, 71.4%) was not significant different from that of patients with no MYCN amplification (n = 32, 90.6%) by FISH (p = 0.11). Conclusions: These results suggested that the MYCN gain detected by FISH represents the 2p gain, and the MYCN gain is not considered to represent the pre-status of MYCN amplification.

AB - Purpose: MYCN amplification (MYCN-A) is a strong prognostic factor in neuroblastoma (NB). MYCN gain which is a low level of MYCN-A as determined by FISH. It is unclear whether the MYCN gain is the pre-status of MYCN-A. This study assessed the status of MYCN gene and chromosome 2p of MYCN-A, MYCN gain and no MYCN amplification using a single nucleotide polymorphism (SNP) array, and the clinical implication of MYCN gain in NB. Methods: The status of the MYCN gene was determined by FISH in 47 primary NB samples and the status of chromosome 2p in all cases was analyzed using an SNP array. Results: 8 of the 47 cases analyzed using FISH showed MYCN-A, 7 cases showed MYCN gain and 32 cases showed no MYCN amplification. An SNP array analysis showed that only 2 of 8 cases with MYCN-A by FISH had both amplification of MYCN region and distal 2p gain and other 6 cases had amplification of the MYCN region without distal 2p gain. All 7 cases with MYCN gain by FISH had distal 2p gain without amplification of the MYCN region, and all 32 cases with no MYCN amplification by FISH demonstrated neither the amplification of the MYCN region nor the 2p gain. 5-year overall survival rate of patients with MYCN gain (n = 7, 71.4%) was not significant different from that of patients with no MYCN amplification (n = 32, 90.6%) by FISH (p = 0.11). Conclusions: These results suggested that the MYCN gain detected by FISH represents the 2p gain, and the MYCN gain is not considered to represent the pre-status of MYCN amplification.

UR - http://www.scopus.com/inward/record.url?scp=79954438367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954438367&partnerID=8YFLogxK

U2 - 10.1007/s00383-010-2781-4

DO - 10.1007/s00383-010-2781-4

M3 - Article

C2 - 21046119

AN - SCOPUS:79954438367

VL - 27

SP - 231

EP - 236

JO - Pediatric Surgery International

JF - Pediatric Surgery International

SN - 0179-0358

IS - 3

ER -